Slowmet (Metformin Hydrochloride)

Slowmet is a pharmaceutical product containing metformin hydrochloride, primarily used for the treatment of type 2 diabetes. The brand is associated with SAVIO (Istituto Biochimico Nazionale), an Italian pharmaceutical group.

Starting from 2024, the parent company Gruppo Savio was acquired by GMM Pharma S.p.A., another Italian pharmaceutical entity. This strategic acquisition aimed to strengthen GMM Pharma's portfolio in the metabolism and chronic disease therapeutic areas. The product is manufactured within Italy, adhering to European pharmaceutical standards, and continues to be a staple in the Italian healthcare market for glycemic control.